Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Scott M. Grundy, David W. Bilheimer, Alan Chait, Luther T. Clark, Margo A. Denke, Richard J. Havel, William R. Hazzard, Stephen B. Hulley, Donald B. Hunninghake, Robert A. Kreisberg, Penny M. Kris‐Etherton, James M. McKenney, Michael A. Newman, Ernst J. Schaefer, Burton E. Sobel, Carolyn A. Somelofski, Milton C. Weinstein, H. Bryan Brewer, James I. Cleeman, Karen A. Donato, Nancy D. Ernst, Jeffrey M. Hoeg, Basil M. Rifkind, Jacques Rossouw, Christopher T. Sempos, Joanne M. Gallivan, Maureen N. Harris, Laurie Quint-Adler·1993·JAMA

DOI 10.1001/jama.269.23.3015

Open this paper in CoChat — free account

Abstract

THE SECOND report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II, or ATP II) presents the National Cholesterol Education Program's updated recommendations for cholesterol management. It is similar to the first in general outline, and the fundamental approach to treatment of high blood cholesterol is comparable. This report continues to identify low-density lipoproteins (LDL) as the primary target of cholesterol-lowering therapy. As in the first report, the second report emphasizes the role of the clinical approach in primary prevention of coronary heart disease (CHD). Dietary therapy remains the first line of treatment of high blood cholesterol, and drug therapy is reserved for patients who are considered to be at high risk for CHD. However, the second report contains new features that distinguish it from the first. These include the following: Increased emphasis on See also pp 3002 and 3009.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

OpenAlex · 10.1001/jama.269.23.3015

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Items 1,101–1,200 of 1,299

Central hypothyroidism and its replacement have a significant influence on cardiovascular risk factors in adult hypopituitary patients
Klose, M., Marina, D., Hartoft-Nielsen, M.-L., Klefter, O., Gavan, V., Hilsted, L., Rasmussen, Å. K., & Feldt-Rasmussen, U. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1610 · Cited by 53
The metabolic syndrome and cardiovascular risk: implications for clinical practice
Eddy, D. M., Schlessinger, L., & Heikes, K. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.28 · Cited by 54
Effects of Prescription Omega-3-Acid Ethyl Esters on Non—High-Density Lipoprotein Cholesterol When Coadministered With Escalating Doses of Atorvastatin
Bays, H. E., McKenney, J., Maki, K. C., Doyle, R. T., Carter, R. N., & Stein, E. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0397 · Cited by 54
Self-citation
Compared effects of surgical and natural menopause on climacteric symptoms, osteoporosis, and metabolic syndrome
Özdemir, S., Çelik, Ç., Görkemli, H., Kıyıcı, A., & Kaya, B. (2009) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2009.03.016 · Cited by 54
Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil
Jonkers, I. J. A. M., Smelt, A. H. M., Ledeboer, M., Hollum, M. E., Biemond, I., Kuipers, F., Stellaard, F., Boverhof, R., Meinders, A. E., Lamers, C. H. B. W., et al. (2003) · Gut · doi:10.1136/gut.52.1.109 · Cited by 54
Is serum C-reactive protein concentration correlated with HbA1c and insulin resistance in Type 2 diabetic men with or without coronary heart disease?
Bahceci, M., Tuzcu, A., Ogun, C., Canoruc, N., Iltimur, K., & Aslan, C. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03345357 · Cited by 53
Meta-analysis of safety of the coadministration of statin with fenofibrate in patients with combined hyperlipidemia
Guo, J., Meng, F., Ma, N., Li, C., Ding, Z., Wang, H., Hou, R., & Qin, Y. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.06.050 · Cited by 53
Metabolic syndrome and chronic disease
Rao, D., Dai, S., Lagacé, R., & Krewski, M. (2014) · Chronic Diseases and Injuries in Canada · doi:10.24095/hpcdp.34.1.06 · Cited by 53
Normal physical activity obliterates the deleterious effects of a high-caloric intake
Krogh-Madsen, R., Pedersen, M., Solomon, T. P. J., Knudsen, S. H., Hansen, L. S., Karstoft, K., Lehrskov-Schmidt, L., Pedersen, K. K., Thomsen, C., Holst, J. J., et al. (2014) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00155.2013 · Cited by 53
Metabolic syndrome and associated cardiovascular risk factors in the treatment of persons with human immunodeficiency virus and severe mental illness
Vergara-Rodriguez, P., Vibhakar, S., & Watts, J. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.07.004 · Cited by 53
Cardiovascular risk assessment in persons with HIV infection in the developing world: comparing three risk equations in a cohort of HIV-infected Thais: Cardiovascular risk in HIV-infected Thais
Edwards-Jackson, N., Kerr, S., Tieu, H., Ananworanich, J., Hammer, S., Ruxrungtham, K., Phanuphak, P., Avihingsanon, A., & for the HIV-NAT 006 Study Team (2011) · HIV Medicine · doi:10.1111/j.1468-1293.2011.00916.x · Cited by 53
Perceptions of Quality‐of‐Life Effects of Treatments for Diabetes Mellitus in Vulnerable and Nonvulnerable Older Patients
Brown, S. E. S., Meltzer, D. O., Chin, M. H., & Huang, E. S. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01757.x · Cited by 53
Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dL: Insights From the National Cardiovascular Data Registry–Practice Innovation and Clinical Excellence Registry
Virani, S. S., Kennedy, K. F., Akeroyd, J. M., Morris, P. B., Bittner, V. A., Masoudi, F. A., Stone, N. J., Petersen, L. A., & Ballantyne, C. M. (2018) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.118.004652 · Cited by 53
Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing's syndrome
Trementino, L., Appolloni, G., Concettoni, C., Cardinaletti, M., Boscaro, M., & Arnaldi, G. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0722 · Cited by 53
microRNA-483 ameliorates hypercholesterolemia by inhibiting PCSK9 production
Dong, J., He, M., Li, J., Pessentheiner, A., Wang, C., Zhang, J., Sun, Y., Wang, W.-T., Zhang, Y., Liu, J., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.143812 · Cited by 53
Triglycerides + high‐density‐lipoprotein‐cholesterol dyslipidaemia, a coronary risk factor in elderly women: the CArdiovascular STudy in the ELderly
Mazza, A., Tikhonoff, V., Schiavon, L., & Casiglia, E. (2005) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2005.00940.x · Cited by 53
Statin use and lower extremity amputation risk in nonelderly diabetic patients
Sohn, M.-W., Meadows, J. L., Oh, E. H., Budiman-Mak, E., Lee, T. A., Stone, N. J., & Pearce, W. B. (2013) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2013.06.069 · Cited by 52
Increased levels of resistin in rotating shift workers: A potential mediator of cardiovascular risk associated with circadian misalignment
Burgueño, A., Gemma, C., Gianotti, T. F., Sookoian, S., & Pirola, C. J. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.12.032 · Cited by 53
Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational study
Meek, C., Wierzbicki, A. S., Jewkes, C., Twomey, P. J., Crook, M. A., Jones, A., & Viljoen, A. (2012) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.657302 · Cited by 52
SCAP ligands are potent new lipid-lowering drugs
Grand-Perret, T., Bouillot, A., Perrot, A., Commans, S., Walker, M., & Issandou, M. (2001) · Nature Medicine · doi:10.1038/nm1201-1332 · Cited by 52
Effect of fenofibrate-mediated increase in plasma homocysteine on the progression of coronary artery disease in type 2 diabetes mellitus
Genest, J., Frohlich, J., & Steiner, G. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.12.022 · Cited by 51
Factors Associated with Obesity in an Adult Mediterranean Population: Influence on Plasma Lipid Profile
Mataix, J., López-Frías, M., Martínez-de-Victoria, E., López-Jurado, M., Aranda, P., & Llopis, J. (2005) · Journal of the American College of Nutrition · doi:10.1080/07315724.2005.10719491 · Cited by 51
Cardiovascular Disease Risk Reduction: The Massachusetts WISEWOMAN Project
Stoddard, A. M., Palombo, R., Troped, P. J., Sorensen, G., & Will, J. C. (2004) · Journal of Women's Health · doi:10.1089/1540999041281106 · Cited by 51
Long-term maintenance of weight loss after lifestyle intervention in frail, obese older adults
Waters, D. L., Vawter, R., Qualls, C., Chode, S., Armamento-Villareal, R., & Villareal, D. T. (2013) · The Journal of nutrition, health and aging · doi:10.1007/s12603-012-0421-5 · Cited by 51
The development and implementation of stroke risk prediction model in National Health Insurance Service's personal health record
Lee, J.-W., Lim, H.-S., Kim, D.-W., Shin, S.-A., Kim, J., Yoo, B., & Cho, K.-H. (2018) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2017.10.007 · Cited by 49
Challenges, concerns and common problems: physiological consequences of spinal cord injury and microgravity
Scott, J. M., Warburton, D. E. R., Williams, D., Whelan, S., & Krassioukov, A. (2011) · Spinal Cord · doi:10.1038/sc.2010.53 · Cited by 50
Effects of fenofibrate on atherogenic dyslipidemia in hypertriglyceridemic subjects
Davidson, M. H., Bays, H. E., Stein, E., Maki, K. C., Shalwitz, R. A., & Doyle, R. (2006) · Clinical Cardiology · doi:10.1002/clc.4960290609 · Cited by 51
Medical Nutrition Therapy and Weight Loss Questions for the Evidence Analysis Library Prevention of Type 2 Diabetes Project: Systematic Reviews
Raynor, H. A., Davidson, P. G., Burns, H., Nadelson, M. D. H., Mesznik, S., Uhley, V., & Moloney, L. (2017) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2017.06.361 · Cited by 50
After the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: implications for fenofibrate.
Sacks, F. M. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.09.073 · Cited by 50
The Emerging Link Between Hypogonadism and Metabolic Syndrome
Guay, A. T. (2009) · Journal of Andrology · doi:10.2164/jandrol.108.006015 · Cited by 50
Statin Underuse and Low Prevalence of LDL-C Control Among U.S. Adults at High Risk of Coronary Heart Disease
Gamboa, C. M., Safford, M. M., Levitan, E. B., Mann, D. M., Yun, H., Glasser, S. P., Woolley, J. M., Robert, R., Farkouh, M., & Muntner, P. (2014) · The American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000292 · Cited by 50
Treatment options for hypertriglyceridemia: From risk reduction to pancreatitis
Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., & Stalenhoef, A. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.10.002 · Cited by 50
Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
on behalf of the FIELD Study Investigators, d’Emden, M. C., Jenkins, A. J., Li, L., Zannino, D., Mann, K. P., Best, J. D., Stuckey, B. G. A., Park, K., Saltevo, J., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3344-3 · Cited by 49
Effects of combination lipid therapy on coronary stenosis progression and clinical cardiovascular events in coronary disease patients with metabolic syndrome: a combined analysis of the Familial Atherosclerosis treatment study (FATS), the HDL-Atherosclerosis treatment study (HATS) and the Armed Forces regression Study (AFREGS)
Zhao, X.-Q., Krasuski, R. A., Baer, J., Whitney, E. J., Neradilek, B., Chait, A., Marcovina, S., Albers, J. J., & Brown, B. G. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.07.035 · Cited by 48
Self-citation
LDL-cholesterol-lowering effect of a dietary supplement with plant extracts in subjects with moderate hypercholesterolemia
Ogier, N., Amiot, M.-J., Georgé, S., Maillot, M., Mallmann, C., Maraninchi, M., Morange, S., Lescuyer, J.-F., Peltier, S. L., & Cardinault, N. (2013) · European Journal of Nutrition · doi:10.1007/s00394-012-0357-x · Cited by 49
Coronary age as a risk factor in the modified Framingham risk score
Schisterman, E. F., & Whitcomb, B. W. (2004) · BMC Medical Imaging · doi:10.1186/1471-2342-4-1 · Cited by 47
Outcomes of a Cardiovascular Nutrition Counseling Program in African-Americans with Elevated Blood Pressure or Cholesterol Level
KUMANYIKA, S. K., ADAMS-CAMPBELL, L., VAN HORN, B., TEN HAVE, T. R., TREU, J. A., ASKOV, E., WILLIAMS, J., ACHTERBERG, C., ZAGHLOUL, S., MONSEGU, D., et al. (1999) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(99)00336-3 · Cited by 48
The Triglyceride-Lowering Effects of a Modest Dose of Docosahexaenoic Acid Alone Versus in Combination with Low Dose Eicosapentaenoic Acid in Patients with Coronary Artery Disease and Elevated Triglycerides
Schwellenbach, L. J., Olson, K. L., McConnell, K. J., Stolcpart, R. S., Nash, J. D., Merenich, J. A., & for the Clinical Pharmacy Cardiac Risk Service Study Group (2006) · Journal of the American College of Nutrition · doi:10.1080/07315724.2006.10719562 · Cited by 48
Subclinical Hypothyroidism has Little Influences on Muscle Mass or Strength in Elderly People
Moon, M. K., Lee, Y. J., Choi, S. H., Lim, S., Yang, E. J., Lim, J.-Y., Paik, N.-J., Kim, K. W., Park, K. S., Jang, H. C., et al. (2010) · Journal of Korean Medical Science · doi:10.3346/jkms.2010.25.8.1176 · Cited by 48
The Prevalence of the Metabolic Syndrome in Korean Adults: Comparison of WHO and NCEP Criteria
Choi, S. H., Ahn, C. W., Cha, B. S., Chung, Y.-S., Lee, K. W., Lee, H. C., Huh, K. B., & Kim, D. J. (2005) · Yonsei Medical Journal · doi:10.3349/ymj.2005.46.2.198 · Cited by 48
A preliminary report on the effects of the level of spinal cord injury on the association between central adiposity and metabolic profile
Gorgey, A. S., & Gater, D. R. (2011) · PM&R · doi:10.1016/j.pmrj.2011.01.011 · Cited by 48
Mipomersen is a promising therapy in the management of hypercholesterolemia: a meta-analysis of randomized controlled trials
Li, N., Li, Q., Tian, X.-Q., Qian, H.-Y., & Yang, Y.-J. (2014) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-014-0077-0 · Cited by 45
Aerobic Exercise and Postprandial Lipemia in Men with the Metabolic Syndrome
MESTEK, M. L., PLAISANCE, E. P., RATCLIFF, L. A., TAYLOR, J. K., WEE, S.-O., & GRANDJEAN, P. W. (2008) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181822ebd · Cited by 47
Differential DNA Methylation in Relation to Age and Health Risks of Obesity
Mansego, M., Milagro, F., Zulet, M., Moreno-Aliaga, M., & Martínez, J. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160816816 · Cited by 47
Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on plasma apolipoprotein C-III levels in patients from the MARINE and ANCHOR studies
Ballantyne, C. M., Bays, H. E., Braeckman, R. A., Philip, S., Stirtan, W. G., Doyle, R. T., Soni, P. N., & Juliano, R. A. (2016) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2016.02.008 · Cited by 47
Association between Sarcopenic Obesity, Type 2 Diabetes, and Hypertension in Overweight and Obese Treatment-Seeking Adult Women
Kreidieh, D., Itani, L., El Masri, D., Tannir, H., Citarella, R., & El Ghoch, M. (2018) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd5040051 · Cited by 46
Effects of moderate (MF) versus lower fat (LF) diets on lipids and lipoproteins: a meta-analysis of clinical trials in subjects with and without diabetes
Cao, Y., Mauger, D. T., Pelkman, C. L., Zhao, G., Townsend, S. M., & Kris-Etherton, P. M. (2009) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2008.12.008 · Cited by 46
Self-citation
An Association of Herpes Simplex Virus Type 1 Infection With Type 2 Diabetes
Sun, Y., Pei, W., Wu, Y., & Yang, Y. (2005) · Diabetes Care · doi:10.2337/diacare.28.2.435 · Cited by 46
The heme oxygenase system attenuates pancreatic lesions and improves insulin sensitivity and glucose metabolism in deoxycorticosterone acetate hypertension
Ndisang, J. F., & Jadhav, A. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.91000.2008 · Cited by 46
Improving adherence to a cholesterol-lowering diet: a behavioral intervention study
Burke, L. E., Dunbar-Jacob, J., Orchard, T. J., & Sereika, S. M. (2005) · Patient Education and Counseling · doi:10.1016/j.pec.2004.05.007 · Cited by 46
Evaluation of the American Heart Association cardiovascular disease prevention guideline for women
Hsia, J., Rodabough, R. J., Manson, J. E., Liu, S., Freiberg, M. S., Graettinger, W., Rosal, M. C., Cochrane, B., Lloyd-Jones, D., Robinson, J. G., et al. (2010) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.108.842385 · Cited by 45
Walking and Non‐HDL‐C in Adults: A Meta‐Analysis of Randomized Controlled Trials
Kelley, G. A., Kelley, K. S., & Tran, Z. V. (2005) · Preventive Cardiology · doi:10.1111/j.1520-037x.2005.3474.x · Cited by 46
The Use of a Single‐Pill Calcium Channel Blocker/Statin Combination in the Management of Hypertension and Dyslipidemia: A Randomized, Placebo‐Controlled, Multicenter Study
Neutel, J. M., Bestermann, W. H., Dyess, E. M., Graff, A., Kursun, A., Sutradhar, S., & Yunis, C. (2009) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.00058.x · Cited by 46
Dietary factors associated with metabolic syndrome and its components in overweight and obese Brazilian schoolchildren: a cross-sectional study
Rinaldi, A. E. M., Gabriel, G. F. C. P., Moreto, F., Corrente, J. E., McLellan, K. C. P., & Burini, R. C. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0178-9 · Cited by 46
Monitoring of lipids, enzymes, and creatine kinase in patients on lipid-lowering drug therapy
Wiklund, O., Pirazzi, C., & Romeo, S. (2013) · Current Cardiology Reports · doi:10.1007/s11886-013-0397-8 · Cited by 45
Insulin Resistance Is Not Strictly Associated with Energy Intake or Dietary Macronutrient Composition in Women with Polycystic Ovary Syndrome
Toscani, M. K., Mario, F. M., Radavelli-Bagatini, S., & Spritzer, P. M. (2011) · Nutrition Research · doi:10.1016/j.nutres.2011.01.009 · Cited by 47
Resistance exercise plus to aerobic activities is associated with better lipids' profile among healthy individuals: the ATTICA study.
Pitsavos, C., Panagiotakos, D. B., Tambalis, K. D., Chrysohoou, C., Sidossis, L. S., Skoumas, J., & Stefanadis, C. (2009) · QJM · doi:10.1093/qjmed/hcp083 · Cited by 45
Impact of baseline physical activity and diet behavior on metabolic syndrome in a pharmaceutical trial: Results from NAVIGATOR
Huffman, K. M., Sun, J.-L., Thomas, L., Bales, C. W., Califf, R. M., Yates, T., Davies, M. J., Holman, R. R., McMurray, J. J. V., Bethel, M. A., et al. (2014) · Metabolism · doi:10.1016/j.metabol.2014.01.002 · Cited by 45
Cardiovascular risk factors in the urban Mexican population: The FRIMEX study
Meaney, E., Lara-Esqueda, A., Ceballos-Reyes, G. M., Asbun, J., Vela, A., Martínez-Marroquín, Y., López, V., Meaney, A., de la Cabada-Tamez, E., Velázquez-Monroy, Ó., et al. (2007) · Public Health · doi:10.1016/j.puhe.2006.11.008 · Cited by 45
Effects of Post‐absorptive and Postprandial Exercise on Glucoregulation in Metabolic Syndrome
Derave, W., Mertens, A., Muls, E., Pardaens, K., & Hespel, P. (2007) · Obesity · doi:10.1038/oby.2007.548 · Cited by 45
Development of a weighted cardiometabolic disease staging (CMDS) system for the prediction of future diabetes
Guo, F., & Garvey, W. T. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2691 · Cited by 44
Night-shift work and cardiovascular risk among employees of a public university
Pimenta, A. M., Kac, G., Campos e Souza, R. R., Maria de Barros Almeida Ferreira, L., & Maria de Fátima Silqueira, S. (2012) · Revista da Associação Médica Brasileira (English Edition) · doi:10.1016/s2255-4823(12)70177-7 · Cited by 44
Egg consumption and cardiovascular disease among diabetic individuals: a systematic review of the literature
Tran, N. L., Barraj, L., Heilman, J., & Scrafford, C. (2014) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s58668 · Cited by 44
Potential cost-effectiveness of C-reactive protein screening followed by targeted statin therapy for the primary prevention of cardiovascular disease among patients without overt hyperlipidemia
Blake, G. J., Ridker, P. M., & Kuntz, K. M. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00074-3 · Cited by 44
Religion and Cardiovascular Disease Risk
Lapane, K. L., Lasater, T. M., Allan, C., & Carleton, R. A. (1997) · Journal of Religion and Health · doi:10.1023/a:1027444621177 · Cited by 44
Utility of genetic determinants of lipids and cardiovascular events in assessing risk
Holmes, M. V., Harrison, S., Talmud, P. J., Hingorani, A. D., & Humphries, S. E. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.6 · Cited by 44
The triglyceride-lowering effect of supplementation with dual probiotic strains, Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032: reduction of fasting plasma lysophosphatidylcholines in nondiabetic and hypertriglyceridemic subjects
Ahn, H. Y., Kim, M., Ahn, Y.-T., Sim, J.-H., Choi, I.-D., Lee, S.-H., & Lee, J. H. (2015) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.05.002 · Cited by 44
Monocyte chemoattractant protein-1: a proinflammatory cytokine elevated in sarcopenic obesity
Chong, M. S., Lim, J. P., Leung, B., Ding, Y. Y., Tay, L., Ismail, N. H., Yeo, A., & Yew, S. (2015) · Clinical Interventions in Aging · doi:10.2147/cia.s78901 · Cited by 43
Obesity and Body Composition in Man and Woman: Associated Diseases and the New Role of Gut Microbiota
Avolio, E., Gualtieri, P., Romano, L., Pecorella, C., Ferraro, S., Palma, G., Di Renzo, L., & De Lorenzo, A. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867326666190326113607 · Cited by 43
Combined hormonal contraceptive use among women with known dyslipidemias: a systematic review of critical safety outcomes
Dragoman, M., Curtis, K. M., & Gaffield, M. E. (2016) · Contraception · doi:10.1016/j.contraception.2015.08.002 · Cited by 43
Smoking increases the risk of all-cause and cardiovascular mortality in patients with chronic kidney disease
Nakamura, K., Nakagawa, H., Murakami, Y., Kitamura, A., Kiyama, M., Sakata, K., Tsuji, I., Miura, K., Ueshima, H., & Okamura, T. (2015) · Kidney International · doi:10.1038/ki.2015.212 · Cited by 43
The early life nutritional environment and early life stress as potential pathways towards the metabolic syndrome in mid-life? A lifecourse analysis using the 1958 British birth cohort
Delpierre, C., Fantin, R., Barboza-Solis, C., Lepage, B., Darnaudéry, M., & Kelly-Irving, M. (2016) · BMC Public Health · doi:10.1186/s12889-016-3484-0 · Cited by 42
Do statins prevent Alzheimer's disease? A narrative review
Daneschvar, H. L., Aronson, M. D., & Smetana, G. W. (2015) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.08.012 · Cited by 42
Hemoglobin A1c (HbA1c) predicts future drug treatment for diabetes mellitus: a follow-up study using routine clinical data in a Japanese university hospital
Shimazaki, T., Kadowaki, T., Ohyama, Y., Ohe, K., & Kubota, K. (2007) · Translational research · doi:10.1016/j.trsl.2006.09.008 · Cited by 42
Plasma Cytokines, Metabolic Syndrome, and Atherosclerosis in Humans
Reilly, M. P., Rohatgi, A., McMahon, K., Wolfe, M. L., Pinto, S. C., Rhodes, T., Girman, C., & Rader, D. J. (2007) · Journal of Investigative Medicine · doi:10.2310/6650.2007.06013 · Cited by 42
Metabolic syndrome in primary aldosteronism and essential hypertension: Relationship to adiponectin gene variants
Ronconi, V., Turchi, F., Rilli, S., Di Mattia, D., Agostinelli, L., Boscaro, M., & Giacchetti, G. (2010) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.03.007 · Cited by 41
Effect of health information technology interventions on lipid management in clinical practice: A systematic review of randomized controlled trials
Aspry, K. E., Furman, R., Karalis, D. G., Jacobson, T. A., Zhang, A. M., Liptak, G. S., & Cohen, J. D. (2013) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2013.10.004 · Cited by 41
Poly is more effective than monounsaturated fat for dietary management in the metabolic syndrome: The muffin study
Miller, M., Sorkin, J. D., Mastella, L., Sutherland, A., Rhyne, J., Donnelly, P., Simpson, K., & Goldberg, A. P. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.04.011 · Cited by 41
Hemodynamic and metabolic responses to valsartan and atenolol in obese hypertensive patients
Jordan, J., Engeli, S., Boschmann, M., Weidinger, G., Luft, F. C., Sharma, A. M., & Kreuzberg, U. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000188734.98463.82 · Cited by 41
Machine learning based risk prediction model for asymptomatic individuals who underwent coronary artery calcium score: Comparison with traditional risk prediction approaches
Han, D., Kolli, K. K., Gransar, H., Lee, J. H., Choi, S.-Y., Chun, E. J., Han, H.-W., Park, S. H., Sung, J., Jung, H. O., et al. (2020) · Journal of Cardiovascular Computed Tomography · doi:10.1016/j.jcct.2019.09.005 · Cited by 41
Plasma lipidomic analysis predicts non-calcified coronary artery plaque in asymptomatic patients at intermediate risk of coronary artery disease
Ellims, A. H., Wong, G., Weir, J. M., Lew, P., Meikle, P. J., & Taylor, A. J. (2014) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeu033 · Cited by 41
Pycnogenol® supplementation improves health risk factors in subjects with metabolic syndrome
Belcaro, G., Cornelli, U., Luzzi, R., Cesarone, Dugall, M., Feragalli, B., Errichi, S., Ippolito, E., Grossi, M. G., Hosoi, M., et al. (2013) · Phytotherapy Research · doi:10.1002/ptr.4883 · Cited by 40
New onset dyslipidemia after renal transplantation: is there a difference between tacrolimus and cyclosporine?
Deleuze, S., Garrigue, V., Delmas, S., Chong, G., Swarcz, I., Cristol, J. P., & Mourad, G. (2006) · Transplantation Proceedings · doi:10.1016/j.transproceed.2006.06.125 · Cited by 39
Diagnosis of insulin resistance and associated syndromes: the spectrum from the metabolic syndrome to type 2 diabetes mellitus
Simonson, G. D., & Kendall, D. M. (2005) · Coronary Artery Disease · doi:10.1097/00019501-200512000-00002 · Cited by 38
Fenofibrate and metabolic syndrome
T. Kraja, A., A. Province, M., J. Straka, R., M. Ordovas, J., B. Borecki, I., & K. Arnett, D. (2010) · Endocrine, Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153010791213047 · Cited by 40
Association of cholesteryl ester transfer protein (CETP) gene polymorphism, high density lipoprotein cholesterol and risk of coronary artery disease: a meta-analysis using a Mendelian randomization approach
Wu, Z., Lou, Y., Qiu, X., Liu, Y., Lu, L., Chen, Q., & Jin, W. (2014) · BMC Medical Genetics · doi:10.1186/s12881-014-0118-1 · Cited by 40
Effect of a High-Protein Energy-Restricted Diet Combined with Resistance Training on Metabolic Profile in Older Individuals with Metabolic Impairments
Amamou, T., Normandin, E., Pouliot, J., Dionne, I. J., Brochu, M., & Riesco, E. (2017) · The Journal of nutrition, health and aging · doi:10.1007/s12603-016-0760-8 · Cited by 40
Cardiovascular burden and related risk factors among Nunavik (Quebec) Inuit: Insights from baseline findings in the circumpolar Inuit Health in Transition cohort study
Chateau-Degat, M.-L., Dewailly, É., Louchini, R., Counil, É., Noël, M., Ferland, A., Lucas, M., BPharm, B. V., Ékoé, J.-M., Ladouceur, R., et al. (2010) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(10)70398-6 · Cited by 40
A pulse-based diet and the Therapeutic Lifestyle Changes diet in combination with health counseling and exercise improve health-related quality of life in women with polycystic ovary syndrome: secondary analysis of a randomized controlled trial
Kazemi, M., McBreairty, L. E., Zello, G. A., Pierson, R. A., Gordon, J. J., Serrao, S. B., Chilibeck, P. D., & Chizen, D. R. (2020) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.1080/0167482x.2019.1666820 · Cited by 40
Effect of Metformin compared with hypocaloric diet on serum C‐reactive protein level and insulin resistance in obese and overweight women with polycystic ovary syndrome
Esfahanian, F., Zamani, M. M., Heshmat, R., & Moini nia, F. (2013) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2012.02051.x · Cited by 38
Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: national Health and Nutrition Examination Survey 2009-2010
Wong, N. D., Chuang, J., Zhao, Y., & Rosenblit, P. D. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.05.003 · Cited by 39
A comparison of non-HDL and LDL cholesterol goal attainment in a large, multinational patient population: The Lipid Treatment Assessment Project 2
Santos, R. D., Waters, D. D., Tarasenko, L., Messig, M., Jukema, J. W., Chiang, C.-W., Ferrieres, J., & Foody, J. M. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.06.052 · Cited by 39
Assessing the incremental role of novel and emerging risk factors.
Cook, N. R. (2010) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-010-0084-x · Cited by 39
Improvements in PCOS characteristics and phenotype severity during a randomized controlled lifestyle intervention
Dietz de Loos, A. L. P., Jiskoot, G., Timman, R., Beerthuizen, A., Busschbach, J. J. V., & Laven, J. S. E. (2021) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2021.05.008 · Cited by 39
Evaluation of cholesterol-lowering activity of standardized extract of Mangifera indica in albino Wistar rats
Dethe, S., Gururaja, G., Mundkinajeddu, D., Kumar, A., Allan, J., & Agarwal, A. (2017) · Pharmacognosy Research · doi:10.4103/0974-8490.199770 · Cited by 39
Relation of habitual snoring with components of metabolic syndrome in Korean adults
Cho, N., Joo, S., Kim, J., Abbott, R. D., Kim, J., Kimm, K., & Shin, C. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.06.011 · Cited by 38
Omega-3 carboxylic acids in patients with severe hypertriglyceridemia: EVOLVE II, a randomized, placebo-controlled trial
Stroes, E. S. G., Susekov, A. V., de Bruin, T. W. A., Kvarnström, M., Yang, H., & Davidson, M. H. (2018) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2017.10.012 · Cited by 38
Diabetes, the Metabolic Syndrome, and Angiographic Progression of Coronary Arterial Disease in Postmenopausal Women
Mellen, P. B., Cefalu, W. T., & Herrington, D. M. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000191656.71812.7c · Cited by 38
A revised definition of the metabolic syndrome predicts coronary artery disease and ischemic stroke after adjusting for low density lipoprotein cholesterol in a 13-year cohort study of Japanese: The Suita Study
Okamura, T., Kokubo, Y., Watanabe, M., Higashiyama, A., Ono, Y., Nishimura, K., Okayama, A., & Miyamoto, Y. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.03.010 · Cited by 38
Impact of glucocorticoid receptor gene polymorphisms on the metabolic profile of adult patients with the classical form of 21-hydroxylase deficiency
Moreira, R. P. P., Gomes, L. G., Mendonca, B. B., & Bachega, T. A. S. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044893 · Cited by 38

Authors: Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., Kris‐Etherton, P. M., McKenney, J. M., Newman, M. A., Schaefer, E. J., Sobel, B. E., Somelofski, C. A., Weinstein, M. C., Brewer, H. B., Cleeman, J. I., Donato, K. A., Ernst, N. D., Hoeg, J. M., Rifkind, B. M., Rossouw, J., Sempos, C. T., Gallivan, J. M., Harris, M. N., & Quint-Adler, L.
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 1993-06-16
Volume: 269
Issue: 23
Pages: 3015
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.269.23.3015
OpenAlex: W4249825849
Cited by: 27,947
References: 0
FWCI: 282.04
Type: journal article
Language: en
Open access: closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cited by

Metadata

Record

About these checks

Data sources